Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Beam Therapeutics Inc.
IPO Date: February 6, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $1.83B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.62 | 3.52%
Avg Daily Range (30 D): $0.90 | 4.79%
Avg Daily Range (90 D): $0.94 | 3.94%
Institutional Daily Volume
Avg Daily Volume: .86M
Avg Daily Volume (30 D): 2.28M
Avg Daily Volume (90 D): 1.59M
Trade Size
Avg Trade Size (Sh.): 57
Avg Trade Size (Sh.) (30 D): 76
Avg Trade Size (Sh.) (90 D): 66
Institutional Trades
Total Inst.Trades: 2,882
Avg Inst. Trade: $3.16M
Avg Inst. Trade (30 D): $2.99M
Avg Inst. Trade (90 D): $2.98M
Avg Inst. Trade Volume: .08M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $4.89M
Avg Closing Trade (30 D): $5.22M
Avg Closing Trade (90 D): $5.6M
Avg Closing Volume: 128.34K
       
News
Mar 10, 2025 @ 10:01 AM
Beam Therapeutics Announces Pricing of Underwritte...
Source: N/A
Feb 24, 2025 @ 12:00 PM
Beam Therapeutics to Participate in Upcoming March...
Source: N/A
Jan 30, 2025 @ 12:00 PM
Beam Therapeutics to Participate in Guggenheim SMI...
Source: N/A
Dec 19, 2024 @ 6:00 PM
Comprehensive Market Analysis of Latest Published ...
Source: Delveinsight
Dec 8, 2024 @ 6:45 PM
Beam Therapeutics Presents New Non-human Primate (...
Source: N/A
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-4.58 $-1.09 $-4.58
Diluted EPS $-4.58 $-1.09 $-4.58
Revenue $ 63.52M $ 30.07M $ 63.52M
Gross Profit $ $ $
Net Income / Loss $ -376.74M $ -90.35M $ -376.74M
Operating Income / Loss $ -415.57M $ -100.04M $ -415.57M
Cost of Revenue $ $ $
Net Cash Flow $ -154.5M $ 53.36M $ -154.5M
PE Ratio